Endogenous asymmetrical dimethylarginine and hypertension associated with puromycin nephrosis in the rat

被引:13
作者
Sato, J
Masuda, H
Tamaoki, S
Hamasaki, H
Ishizaka, K
Matsubara, O
Azuma, H
机构
[1] Tokyo Med & Dent Univ, Inst Med & Dent Engn, Dept Med Chem, Chiyoda Ku, Tokyo 1010062, Japan
[2] Tokyo Med & Dent Univ, Fac Med, Dept Urol, Chiyoda Ku, Tokyo 1010062, Japan
[3] Natl Def Med Coll, Dept Pathol, Tokorozawa, Saitama 3590042, Japan
关键词
ADMA; endogenous NOS inhibitor; FSGS; hypertension; puromycin;
D O I
10.1038/sj.bjp.0702101
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The present experiments were designed to investigate the role of asymmetrical N-G,N-G-dimethyl-L-arginine (ADMA) in causing hypertension associated with the focal and segmental glomerulosclerosis (FSGS) produced by a single bolus of puromycin aminonucleoside (PAN) and successive injection of protamine for 7 days in rats which had undergone unilateral nephrectomy. 2 After the unilateral nephrectomy, and administering PAN and protamine, histological examinations of the kidney revealed a typical FSGS, that is, evident abnormalities including segmental mesangial proliferation, obliteration of glomerular capillary lumens and adhesions between the glomerulus and Bowman's capsule could be observed. Changes in the glomerular epithelial cells consisted of the swelling with bleb formation. 3 In the FSGS rats, urine volume and urinary protein were significantly (P<0.05 and P<0.005) increased throughout 4-week experimental period, while the creatinine clearance was significantly (P<0.005) and transiently decreased, and recovered 4 weeks later. These changes were associated with the sustained elevation of the systolic blood pressure. 4 ADMA levels in aortic endothelial cells, plasma and urine were significantly (P<0.05 and P<0.005) increased in the FSGS rats, but the level in the kidney remained unchanged. 5 The basal level and net production of cyclic GMP in the aortic vessel wall with endothelium when stimulated by norepinephrine and acetylcholine were significantly (P<0.05 and P<0.01) attenuated in the FSGS rats. 6 There were significant and positive correlations between systolic blood pressure (y) and ADMA levels (x) in endothelial cells (y=4.43x+122.2, r=0.979, P<0.0001), plasma (y=0.10x+71.9, r=0.921, P<0.001) and urine (y=0.48x+126.9, r=0.699, P<0.005), but not significant in the kidney (y=0.06x+102.7, r=0.252, NS). 7 These findings suggest that ADMA as an endogenous inhibitor of NO synthesis may play an important role for the pathogenesis in the hypertension associated with the experimental FSGS in the rat.
引用
收藏
页码:469 / 476
页数:8
相关论文
共 44 条
[1]   NG-METHYLARGININE, AN INHIBITOR OF ENDOTHELIUM-DERIVED NITRIC-OXIDE SYNTHESIS, IS A POTENT PRESSOR AGENT IN THE GUINEA-PIG - DOES NITRIC-OXIDE REGULATE BLOOD-PRESSURE INVIVO [J].
AISAKA, K ;
GROSS, SS ;
GRIFFITH, OW ;
LEVI, R .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 160 (02) :881-886
[2]   ACCUMULATION OF ENDOGENOUS INHIBITORS FOR NITRIC-OXIDE SYNTHESIS AND DECREASED CONTENT OF L-ARGININE IN REGENERATED ENDOTHELIAL-CELLS [J].
AZUMA, H ;
SATO, J ;
HAMASAKI, H ;
SUGIMOTO, A ;
ISOTANI, E ;
OBAYASHI, S .
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 115 (06) :1001-1004
[3]   A possible role of endogenous inhibitor for nitric oxide synthesis in the bovine ciliary muscle [J].
Azuma, H ;
Masuda, H ;
Sato, J ;
Niwa, K ;
Tokoro, T .
EXPERIMENTAL EYE RESEARCH, 1997, 64 (05) :823-830
[4]   CHRONIC GLOMERULONEPHRITIS - NON-IMMUNOLOGIC MECHANISMS OF PROGRESSIVE GLOMERULAR DAMAGE [J].
BALDWIN, DS ;
COHEN, JJ ;
HARRINGTON, JT ;
KASSIRER, JP ;
CLIVE, D ;
MADIAS, NE ;
STROM, J ;
ZELMAN, S ;
MADAIO, M .
KIDNEY INTERNATIONAL, 1982, 21 (01) :109-120
[5]   Elevated L-arginine/dimethylarginine ratio contributes to enhanced systemic NO production by dietary L-arginine in hypercholesterolemic rabbits [J].
BodeBoger, SM ;
Boger, RH ;
Kienke, S ;
Junker, W ;
Frolich, JC .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 219 (02) :598-603
[6]   INDUCTION OF N-G-MONOMETHYL-L-ARGININE UPTAKE - A MECHANISM FOR DIFFERENTIAL INHIBITION OF NO SYNTHASES [J].
BOGLE, RG ;
MACALLISTER, RJ ;
WHITLEY, GS ;
VALLANCE, P .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 1995, 269 (03) :C750-C756
[7]  
BRENNER BM, 1982, NEW ENGL J MED, V307, P652, DOI 10.1056/NEJM198209093071104
[8]  
CHU A, 1990, AM J PHYSIOL, V258, pH1250, DOI 10.1152/ajpheart.1990.258.4.H1250
[9]  
DIAMOND JR, 1986, AM J PATHOL, V122, P481
[10]  
EBIHARA I, 1993, J AM SOC NEPHROL, V3, P1387